ETV4 and neoplasm: ETS variant 4 (ETV4), a member of the polyoma enhancer activator protein (PEA3) subgroup [35, 60], has been found to exhibit abnormal expression in various tumors, thereby facilitating tumor development and metastasis [61–64].